Vireo Growth Inc. Turns $1M Loss Into $5.8M Gain In Q2: What Investors Need To Know About This Cannabis Stock
Vireo Growth Inc. Turns $1M Loss Into $5.8M Gain In Q2: What Investors Need To Know About This Cannabis Stock
Vireo Growth Inc. (OTC:VREOF) announced its financial results for the second quarter of June 30, 2024. The cannabis company reported significant year-over-year growth in several key financial metrics.
Vireo Growth Inc.（場外交易代碼：VREOF）宣佈2024年6月30日第二季度財務業績。這家大麻股公司報告稱，在幾個重要的財務指標上實現了顯著的同比增長。
CEO Josh Rosen commented on the results: "We were pleased to recently activate recreational wholesale sales in New York after receiving our ROND license in July and are continuing to work through our ongoing divestiture process."
CEO Josh Rosen在談到業績時表示：“我們很高興在7月獲得ROND許可證後能夠在紐約激活休閒批發銷售，並正在繼續進行我們持續的剝離過程。”
The company's revenue for the second quarter was $22.5 million, excluding discontinued operations and New York, marking a 42.5% increase from the same period in 2023.
該公司在第二季度營業收入爲2250萬美元，不包括停產業務和紐約，較2023年同期增長42.5%。
The GAAP gross profit rose to $13.6 million, a 45.2% increase, with a gross margin of 54.0%. This compares to a gross profit of $9.3 million and a gross margin of 46.2% in the previous year.
按照GAAP計算的毛利潤爲1360萬美元，增長了45.2％，毛利率爲54.0％。相比之下，去年同期毛利潤爲930萬美元，毛利率爲46.2％。
Amber Shimpa, president and CEO of Vireo Health of Minnesota, added, "Our core market key performance indicators reflect more stable year-over-year comparisons."
Vireo Health of Minnesota的總裁兼首席執行官Amber Shimpa補充道：“我們核心市場的關鍵業績指標顯示出更穩定的年度對比。”
Net Loss and Operating Income
淨虧損和營業收益
Vireo's net loss for the quarter was not explicitly stated in the press release. However, the company reported an operating income of $5.8 million, a significant improvement from a loss of $1.0 million in Q2 2023.
在新聞發佈會上未明確說明Vireo的淨虧損。但是，公司報告其營業收入爲580萬美元，相較於2023年第二季度的損失100萬美元有了顯著的改善。
The adjusted EBITDA was $8.1 million, up 185.7% from $2.8 million in the same quarter last year.
調整後的EBITDA爲810萬美元，比去年同期的280萬美元增長了185.7％。
SG&A Expenses and Financial Stability
銷售、一般及行政開支和財務穩定性
Vireo's selling, general, and administrative (SG&A) expenses decreased by 6.1% to $7.6 million, representing 30.1% of sales, down from 39.9% in the previous year.
Vireo的銷售、一般及行政開支（SG&A）減少了6.1％，至760萬美元，佔銷售額的30.1％，低於去年的39.9％。
The company reported securing a 30-month extension of its credit agreement.
該公司報告已獲得其信貸協議的30個月延長。
Balance Sheet And Liquidity
資產負債表和流動性
As of June 30, 2024, Vireo's total current assets were $148.6 million, with $11.2 million in cash. Total current liabilities, excluding extended debt, were $126.3 million, including $88.4 million in liabilities held for sale related to the company's New York operations.
截至2024年6月30日，Vireo的總流動資產爲14860萬美元，現金爲1120萬美元。除了延長的債務外，總流動負債爲12630萬美元，包括與公司的紐約業務有關的8840萬美元待售負債。
Convertible Notes
可轉換債券
In addition to financial performance, Vireo reported other significant events, including a non-brokered private placement and a name change to Vireo Growth Inc. The company also amended its credit agreement and saw an early conversion of convertible notes, resulting in interest expense savings.
除了財務績效以外，Vireo還報告了其他重大事件，包括定向增發以及更名爲Vireo Growth Inc。公司還修改了其信貸協議，並看到可轉換票據的提前轉換，導致了利息費用的節省。
Price Action: Vireo Growth Inc. (VREOF) stock price increased by 5.83%, closing at $0.455050 on August 6.
價格走勢：Vireo Growth Inc.（VREOF）股價上漲5.83％，8月6日收於0.455050美元。
These issues will be among the hot topics at the upcoming Benzinga Cannabis Capital Conference in Chicago this Oct. 8-9. Join us to get more insight into what the wave of weed legalization means for the future of investing in the industry. Hear directly from top executives, investors, advocates, and policymakers. Get your tickets now before prices go up by following this link.
這些問題將是即將到來的芝加哥Benzinga大麻資本會議的熱門話題，時間是10月8日至9日。加入我們，以獲取關於大麻合法化浪潮對該行業投資未來意味着什麼的更深入了解。直接聽取高管，投資者，倡導者和政策制定者的意見。在通過此鏈接購買門票之前，抓緊時間，因爲價格會上漲。
Photo: AI-generated image.
照片：人工智能生成的圖像。
譯文內容由第三人軟體翻譯。